tiprankstipranks
Pyxis Oncology (PYXS)
NASDAQ:PYXS
US Market

Pyxis Oncology (PYXS) Technical Analysis

Compare
443 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Pyxis Oncology’s (PYXS) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting Pyxis Oncology is a Buy.
Pyxis Oncology’s (PYXS) 20-Day exponential moving average is 1.30, while Pyxis Oncology’s (PYXS) share price is $1.11, making it a Sell.
Pyxis Oncology’s (PYXS) 50-Day exponential moving average is 1.58, while Pyxis Oncology’s (PYXS) share price is $1.11, making it a Sell.

Pyxis Oncology (PYXS) Pivot Points

Mar 04, 2025, 06:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.02
1.06
1.13
1.17
1.24
1.28
1.35
Fibonacci
1.06
1.11
1.13
1.17
1.22
1.24
1.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pyxis Oncology (PYXS) Moving Averages

Mar 04, 2025, 06:20 AM
Period
Simple
Exponential
MA5
1.15Sell
1.16Sell
MA10
1.23Sell
1.21Sell
MA20
1.31Sell
1.30Sell
MA50
1.48Sell
1.58Sell
MA100
2.28Sell
2.10Sell
MA200
2.93Sell
2.86Sell
Pyxis Oncology’s (PYXS) 10-Day exponential moving average is 1.21, while Pyxis Oncology’s (PYXS) share price is $1.11, making it a Sell.
Pyxis Oncology’s (PYXS) 100-Day exponential moving average is 2.10, while Pyxis Oncology’s (PYXS) share price is $1.11, making it a Sell.
Pyxis Oncology’s (PYXS) stock price is $1.11 and Pyxis Oncology’s (PYXS) 50-day simple moving average is 1.48, creating a Sell signal.
Pyxis Oncology’s (PYXS) stock price is $1.11 and Pyxis Oncology’s (PYXS) 100-day simple moving average is 2.28, creating a Sell signal.
Pyxis Oncology’s (PYXS) stock price is $1.11 and Pyxis Oncology’s (PYXS) 200-day simple moving average is 2.93, creating a Sell signal.

Pyxis Oncology (PYXS) Technical Indicators

Mar 04, 2025, 06:20 AM
Name
Value
Implied Action
RSI (14)
28.73
Buy
STOCH (9,6)
12.10
Buy
STOCHRSI (14)
10.97
Buy
MACD (12,26)
-0.11
Buy
ADX (14)
23.02
Neutral
Williams %R
-98.31
Buy
CCI (14)
-122.60
Buy
ATR (14)
0.10
-
Ultimate Oscillator
27.15
Sell
ROC
-16.54
Sell
Pyxis Oncology’s (PYXS) Relative Strength Index (RSI) is 28.73, creating a Buy signal.
Pyxis Oncology’s (PYXS) Trend Strength Indicator (ADX) is 23.02, creating a Neutral signal.
Pyxis Oncology’s (PYXS) Commodity Channel Index (CCI) is -122.60, creating a Buy signal.
Pyxis Oncology’s (PYXS) Price Rate of Change (ROC) is -16.54, creating a Sell signal.

FAQ

Is PYXS a Buy, Hold, or Sell?
Based on PYXS’s technical indicators, PYXS is a Sell.
    What is PYXS’s RSI (14)?
    PYXS’s RSI (14) is 28.73, which suggests PYXS is a Buy.
      What is PYXS’s MACD?
      PYXS’s MACD is -0.11, which suggests PYXS is a Buy.
        What is PYXS’s 5-day moving average?
        PYXS’s 5-day moving average is 1.15, which suggests PYXS is a Sell.
          What is PYXS’s 20-day moving average?
          PYXS 20-day moving average is 1.31, which suggests PYXS is a Sell.
            What is PYXS’s 50-day moving average?
            PYXS’s 50-day moving average is 1.48, which suggests PYXS is a Sell.
              What is PYXS’s 200-day moving average?
              PYXS’s 200-day moving average is 2.93, which suggests PYXS is a Sell.
                What is PYXS’s Williams % R (14)?
                PYXS’s Williams % R (14) is -98.31, which suggests PYXS is a Buy.
                  What is PYXS’s CCI (14)?
                  PYXS’s CCI (14) is -122.60, which suggests PYXS is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis